In last trading session, Spruce Biosciences Inc (NASDAQ:SPRB) saw 0.35 million shares changing hands with its beta currently measuring 2.41. Company’s recent per share price level of $0.40 trading at $0.02 or 4.68% at ring of the bell on the day assigns it a market valuation of $16.52M. That closing price of SPRB’s stock is at a discount of -1387.5% from its 52-week high price of $5.95 and is indicating a premium of 7.5% from its 52-week low price of $0.37. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.44 million shares which gives us an average trading volume of 576.80K if we extend that period to 3-months.
For Spruce Biosciences Inc (SPRB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.2 in the current quarter.
Spruce Biosciences Inc (NASDAQ:SPRB) trade information
Upright in the green during last session for gaining 4.68%, in the last five days SPRB remained trading in the green while hitting it’s week-highest on Tuesday, 12/17/24 when the stock touched $0.40 price level, adding 4.31% to its value on the day. Spruce Biosciences Inc’s shares saw a change of -86.35% in year-to-date performance and have moved 4.38% in past 5-day. Spruce Biosciences Inc (NASDAQ:SPRB) showed a performance of -18.37% in past 30-days. Number of shares sold short was 30676.0 shares which calculate 0.1 days to cover the short interests.
Spruce Biosciences Inc (SPRB) estimates and forecasts
Statistics highlight that Spruce Biosciences Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -25.94% of value to its shares in past 6 months, showing an annual growth rate of 19.35% while that of industry is 17.40. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to fall -49.52% from the last financial year’s standing.
5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 885k for the same. And 4 analysts are in estimates of company making revenue of 500k in the next quarter. Company posted 2.89M and 2M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -22.95% during past 5 years.
Spruce Biosciences Inc (NASDAQ:SPRB)’s Major holders
Insiders are in possession of 10.51% of company’s total shares while institution are holding 46.69 percent of that, with stock having share float percentage of 52.17%. Investors also watch the number of corporate investors in a company very closely, which is 46.69% institutions for Spruce Biosciences Inc that are currently holding shares of the company. RIVERVEST VENTURE MANAGEMENT LLC is the top institutional holder at SPRB for having 2.94 million shares of worth $1.52 million. And as of 2024-06-30, it was holding 7.1449 of the company’s outstanding shares.
The second largest institutional holder is CARLYLE GROUP INC., which was holding about 2.9 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.0481 of outstanding shares, having a total worth of $1.52 million.
